Filter
1412
Text search:
poor
mental
health
outcome
Featured
153
359
Language
Document type
912
198
158
78
37
20
3
3
2
1
Countries / Regions
71
55
48
45
34
34
33
28
25
25
23
23
22
21
18
16
16
15
14
13
13
12
11
10
9
8
8
7
7
7
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
486
95
92
87
70
26
5
Toolboxes
270
97
65
63
60
60
39
33
32
31
30
28
21
14
13
12
7
7
7
5
5
4
3
3
3
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
Zambia Report for 2017
Accessed Febr. 6, 2020
WHO Technical Series 971
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable diseases and rapid urbanizat
...
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Standard Treatment Guideline
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)